Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Nov 23, 2016
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Award
Warrant (right to buy)
2016-11-23+13,150→ 13,150 totalExercise: $10.79From: 2017-05-24Exp: 2021-11-23→ Common Stock (13,150 underlying) - Award
Common Stock
2016-11-23$9.12/sh+13,150$119,928→ 53,300 total